Prosecution Insights
Last updated: April 19, 2026

Alector LLC

6 pending office actions

Portfolio Summary

6
Total Pending OAs
2
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18551963 ANTI-TMEM106B ANTIBODIES FOR TREATING AND PREVENTING CORONAVIRUS INFECTIONS GODDARD, LAURA B 1642 Non-Final OA Sep 22, 2023
18310207 ANTI-MS4A4A ANTIBODIES AND METHODS OF USE THEREOF WEIDNER, ADAM M 1675 Non-Final OA May 01, 2023
17916728 METHODS OF USE OF ANTI-TREM2 ANTIBODIES BRISTOL, LYNN ANNE 1643 Final Rejection Oct 03, 2022
17784579 METHODS OF USE OF ANTI-CD33 ANTIBODIES WANG, CHANG YU 1675 Final Rejection Jun 10, 2022
17782127 METHODS OF USE OF ANTI-TREM2 ANTIBODIES WANG, CHANG YU 1675 Non-Final OA Jun 02, 2022
17459835 ANTI-CD33 ANTIBODIES AND METHODS OF USE THEREOF BALLARD, KIMBERLY 1675 Non-Final OA Aug 27, 2021

Managing Alector LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month